Health And Fitness

Provenge FDA Approval Granted for Prostate Cancer Treatment

Provenge FDA Approval Granted for Prostate Cancer Treatment

On April 29, 2010, the FDA approved Provenge, a drug originally slated as a prostate cancer vaccine, as a treatment for use on advanced prostate cancer patients. Although the drug neither prevents, nor cures prostate cancer, the drug was shown to extend the lives of men with advanced prostate cancer by four months. Patients now

Provenge FDA Approval Granted for Prostate Cancer Treatment Read More »